Imerys S.A.
IMYSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.58 | -9.05 | 0.02 |
| FCF Yield | 4.67% | 7.10% | 1.51% | 5.67% |
| EV / EBITDA | 10.65 | 9.34 | 7.54 | 7.64 |
| Quality | ||||
| ROIC | 12.47% | 0.22% | 3.31% | 3.44% |
| Gross Margin | 66.83% | 61.49% | 62.82% | 64.88% |
| Cash Conversion Ratio | -5.16 | 12.27 | 1.78 | 2.17 |
| Growth | ||||
| Revenue 3-Year CAGR | -5.57% | 1.17% | 4.07% | -5.59% |
| Free Cash Flow Growth | -46.33% | 345.85% | -74.78% | -34.23% |
| Safety | ||||
| Net Debt / EBITDA | 3.75 | 3.58 | 2.68 | 2.39 |
| Interest Coverage | 3.50 | 2.63 | 8.38 | 7.01 |
| Efficiency | ||||
| Inventory Turnover | 1.65 | 1.99 | 2.02 | 1.52 |
| Cash Conversion Cycle | 155.08 | 127.43 | 99.04 | 114.78 |